The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...
StockStory.org on MSN
A look back at drug development inputs & services stocks’ Q4 earnings: Repligen (NASDAQ:RGEN) vs the rest of the pack
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...
The positions in the table below reflect the Labcorp Drug Development's position overall, domestically, within their sector, and in various subject areas based on their Share. Each position links to ...
Illumina, Inc. (NASDAQ: ILMN) and Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced an expanded ...
Headquartered in Northwood, Ohio, Namsa provides medical device testing, clinical research and regulatory consulting to medtech companies This acquisition is Namsa’s 10 th acquisition since becoming ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results